VENTURE ADVANCED THERAPIES LIMITED

Company Registration Number:
12465071 (England and Wales)

Unaudited abridged accounts for the year ended 31 March 2023

Period of accounts

Start date: 01 April 2022

End date: 31 March 2023

VENTURE ADVANCED THERAPIES LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2023

Balance sheet
Notes

VENTURE ADVANCED THERAPIES LIMITED

Balance sheet

As at 31 March 2023


Notes

2023

2022


£

£
Fixed assets
Tangible assets: 3 3 176
Total fixed assets: 3 176
Current assets
Debtors:   12,800 11,410
Cash at bank and in hand: 173,086 200,083
Total current assets: 185,886 211,493
Creditors: amounts falling due within one year:   (27,406) (33,249)
Net current assets (liabilities): 158,480 178,244
Total assets less current liabilities: 158,483 178,420
Total net assets (liabilities): 158,483 178,420
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 158,383 178,320
Shareholders funds: 158,483 178,420

The notes form part of these financial statements

VENTURE ADVANCED THERAPIES LIMITED

Balance sheet statements

For the year ending 31 March 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 05 October 2023
and signed on behalf of the board by:

Name: Dr S Theoharis
Status: Director

The notes form part of these financial statements

VENTURE ADVANCED THERAPIES LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2023

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

VENTURE ADVANCED THERAPIES LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2023

2. Employees

2023 2022
Average number of employees during the period 1 1

VENTURE ADVANCED THERAPIES LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2023

3. Tangible Assets

Total
Cost £
At 01 April 2022 524
At 31 March 2023 524
Depreciation
At 01 April 2022 348
Charge for year 173
At 31 March 2023 521
Net book value
At 31 March 2023 3
At 31 March 2022 176

VENTURE ADVANCED THERAPIES LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2023

4. Related party transactions

During the period, total dividends of £96,000 were paid to the director (2022 - £40,000)